HSE have published their latest bulletins:
Biocides
- Upcoming GB active substance expiry dates
Biocidal products must be phased off the GB market
The active substance/product type combinations listed below are due to expire under the GB BPR on the following dates:
- Margosa extract from the kernels of Azadirachata Indica extracted with water and further processed with organic solvents (CAS 84696-25-3 EC 283-644-7) in product type 18
(deadline: 30 April 2024)
- Undecan-2-one (methyl nonyl ketone) (CAS 112-12-9 EC 203-937-5) in product type 19
(deadline: 30 April 2024)
- 1-(4-chlorophenyl)-3-(2,6-difluorobenzoyl)urea (Diflubenzuron) (CAS 35367-38-5 EC 252-529-3) in product type 18 (deadline: 31 January 2025)
- Formaldehyde (CAS 50-00-0 EC 200-001-8) in product type 2 (deadline: 31 January 2025)
- Powdered corn cob (CAS n/a EC n/a) in product type 14 (deadline: 31 January 2025)
- Thiamethoxam (CAS 153719-23-4 EC 428-650-4) in product type 18 (deadline: 31 January 2025)
- 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile (Chlorfenapyr) (CAS 122453-73-0 EC n/a) in product type 8 (deadline: 30 April 2025)
Once the approvals expire, the active substances can no longer be used in biocidal products or treated articles of the relevant product types in Great Britain.
If you hold an affected GB BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision.
If you are aware of any disproportionate negative impacts that are likely to arise from the expiry of any of the active substance/product type combinations listed above, please contact us.
- Margosa extract from the kernels of Azadirachata Indica extracted with water and further processed with organic solvents (CAS 84696-25-3 EC 283-644-7) in product type 18
- Upcoming GB active substance dossier submission deadlines
Take action to keep your active substance in the GB Review Programme
The active substance/product type combinations listed below have been successfully notified into the GB Review Programme following open invitations. The next step is for a full active substance dossier to be submitted to HSE by the following deadlines:
- N-Didecyl-N-dipolyethoxyammonium borate / Didecylpolyoxethylammonium (Polymeric betaine) (CAS 214710-34-6 EC n/a) in product type 8 (deadline: 5 January 2025)
- Active chlorine generated from sodium chloride by electrolysis (CAS 7782-50-5 EC n/a) in product types 2, 3, 4, 5 and 11 (deadline: 17 April 2025)
Only the person, company or task force/consortium that successfully notified the active substance/product type combinations listed above can submit a dossier.
If any of these active substance/product type combinations are important to you, consider contacting the notifier to let them know. You may even be able to join them in supporting the active substance.
Check the list of successful notifiers
If a dossier is not submitted by the deadline, these active substance/product type combinations will be subject to a GB non-approval decision. Biocidal products and treated articles containing active substances with GB non-approval decisions for the relevant product types will have to be removed from the GB market. HSE will provide separate updates on these where relevant.
- N-Didecyl-N-dipolyethoxyammonium borate / Didecylpolyoxethylammonium (Polymeric betaine) (CAS 214710-34-6 EC n/a) in product type 8 (deadline: 5 January 2025)
Classification Labelling and Packaging (CLP)
- Publication of GB mandatory classification and labelling (GB MCL) Agency Opinions
A GB MCL Agency Opinion formally proposes the GB mandatory classification and labelling for chemical substances, based on the scientific and technical assessment of the scientific data in line with the GB CLP Regulation, together with an assessment of the policy and socio-economic impacts on the UK.
It sets out whether there is adequate scientific evidence to support a new or revised GB MCL of a substance and what the potential impact of the proposed GB MCL may be.
The next batch of 2 GB MCL Agency Opinions are now available for download in the GB MCL publication table (.xlsx).
These GB MCL Agency Opinions relate to substances for which HSE (as the GB CLP Agency) published an Agency Technical Report under Article 37 of the GB CLP Regulation in February 2023.
At the time of publication, the classification and labelling proposed in this Agency Opinion has not been agreed and/or adopted in GB.
For information on the next steps in the process, please see our webpage on the GB MCL system.
We expect to publish our next batch of Agency Opinions in late February 2024. CLP ebulletin alerts will be issued when Agency Opinions are published on the HSE website.
If you have any questions or feedback on the GB MCL Agency Opinions, please contact us at: GBCLP.GBMCL@hse.gov.uk Journalists should contact HSE’s press office for further information.
